On Friday 21 August, contributors to the Collaborative Research Programme in Biomedical Innovation Law (CeBIL) convened for the second of two virtual retreats hosted by the University of Copenhagen. Progress updates were provided for the precision medicine, biologics, and synergy & policy solutions studies.
Dr Kathy Liddell (Director of LML) and Prof. Mateo Aboy (Principal Research Associate) began with an overview of LML’s contributions to the synergy study. This year, the Cambridge team worked towards four over-arching objectives in connection with the synergy study:
- Conducting additional research to complement the five core CeBIL studies
- Cross-cutting research on health information governance
- The development of empirical methodologies
- Preparing timely responses to the legal issues raised by the Covid-19 pandemic
Laura Bradford (Senior Research Associate) was also presented the results of her research into cross-border transfers of personal health data. Her paper, co-authored with Mateo Aboy and Kathy Liddell, ‘International Transfers of Health Data between the EU and US: A better approach for the US to ensure an ‘adequate’ level of protection’, is forthcoming in the Journal of Law and the Biosciences.